Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02072421 · ClinicalTrials.gov registry record · NA
The MASS COMM Post-Randomization Phase Cohort Study
A NA study, sponsored by Baim Institute for Clinical Research.
- Completed
- Registry status
- NA
- Development phase
- 2,879
- Enrollment target
NCT02072421: Completed NA study, sponsored by Baim Institute for Clinical Research.
NCT02072421 is a NA study that has completed, run by Baim Institute for Clinical Research. The registered enrollment target is 2,879 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (105% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02072421, a NA study, has completed, sponsored by Baim Institute for Clinical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,879 participants
- Enrollment target
Study Summary
The primary objective of the Post-Randomization Phase Cohort Study is to continue to assess the safety of non-emergency PCI performed at hospitals without cardiac surgery on-site in patients with myocardial ischemia (other than ST-segment elevation myocardial infarction \[STEMI\]).
Primary Outcome
MACE is a composite of all cause mortality, myocardial infarction (Q wave and non-Q wave), repeat coronary revascularization (of the target vessel or non-target vessel) by either percutaneous or coronary artery bypass graft (CABG) methods, or stroke, at 30-days.
Interventions
- PROCEDURE PCI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,879 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-10 |
| Phase | NA |
What the finished NCT02072421 record still lists
NCT02072421 is an interventional study that assigns participants to a tested intervention. Its 2,879 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (105% higher).
The record links to 0 conditions, and to 1 intervention - of which PCI is the first listed.
NCT02072421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02072421 about?
NCT02072421 is a clinical study titled "The MASS COMM Post-Randomization Phase Cohort Study". The primary objective of the Post-Randomization Phase Cohort Study is to continue to assess the safety of non-emergency PCI performed at hospitals without cardiac surgery on-site in patients with myocardial ischemia (other than ST-segment elevation myocardial infarction \[STEMI\]).
What is the current status of trial NCT02072421?
This trial is currently completed. It is a NA study. The enrollment target is 2,879 participants. The study started on 2011-10. Estimated completion is 2013-10.
What interventions are being tested in trial NCT02072421?
The interventions under investigation include: PCI (PROCEDURE).
Who is sponsoring clinical trial NCT02072421?
This trial is sponsored by Baim Institute for Clinical Research, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02072421's enrollment target sits among peer trials
2,879 43rd of 2000 higher than 1,958 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05624450 · 2,870 participants · Phase 3
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- NCT06351085 · 2,869 participants · NA
Enhancing Lung Cancer Screening Through Human-Centered Intervention
- NCT06273436 · 2,894 participants · NA
Healing, Equity, Advocacy and Respect for Mamas
- NCT05564377 · 2,900 participants · Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia